Coronavirus Disease: Existing Literature and Status in India
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 7, Pages 5707-5715
AbstractThe outbreak of COVID-19 disease began in December 2019 in the city of Wuhan in China, also recognized as China's largest transport centre. The condition became epidemic during China's spring festival. The virus is quickly transported into several nations, including countries with low wages So far, 234073 have registered COVID-19 cases in the world with a total of 9840 fatalities. Cough, high fever, a sore throat, tiredness and respiratory trauma are the typical signs of COVID-19. The condition was shown to be moderate in most cases, others with pneumonia with multi-organ failure and acute ARDS. The Incubation Time for the infection has been observed to be 2-14 days, typically 4 days in maximum cases. India remains in stage 2 on local transmission in line with WHO Record 60. The WHO announced 60 that no population transmission has yet occurred in India that can be avoided by preventing mass meetings and proper citizens screens. Govt. Govt. There have been several initiatives by India to minimize the spread of COVID-19 in the region. The COVID-19 infection incidence in India appears to be poor in comparison to the country's population. This is attributable to swift government measures to quarantine and close down the boundaries of the accused population. The global economy is in great slowdown due to COVID-19 assault and would potentially cost roughly $1 trillion. This is attributable to swift government measures to quarantine and close down the boundaries of the accused population. By reducing H-H transmissions, the spread of COVID-19 infections may be minimized. Anti-CoV drug discovery is also required, and will replace the supporting therapies for infection control.
- Article View: 162
- PDF Download: 198